Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial - Todd, J; Evangelou, M; Cutler, AJ; Pekalski, ML; Walker, NM; Stevens, HE; Porter, L; Smyth, DJ; Rainbow, DB; Ferreira, RC; Esposito, L; Hunter, KMD; et al. (PLOS Medicine, 2016)